BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6166230)

  • 1. VAB-6 combination chemotherapy in disseminated cancer of the testis.
    Vugrin D; Herr HW; Whitmore WF; Sogani PC; Golbey RB
    Ann Intern Med; 1981 Jul; 95(1):59-61. PubMed ID: 6166230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VAB-6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis.
    Vugrin D; Whitmore WF; Golbey RB
    Cancer; 1983 Jan; 51(2):211-5. PubMed ID: 6185197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
    Vugrin D; Whitmore WF; Golbey RB
    J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VAB-6 combination chemotherapy in resected stage II-B testis cancer.
    Vugrin D; Whitmore WF; Herr HW; Sogani P; Golbey RB
    Cancer; 1983 Jan; 51(1):5-8. PubMed ID: 6185195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer.
    Vugrin D; Whitmore WF; Herr H; Sogani P; Golbey RB
    J Urol; 1982 Oct; 128(4):715-7. PubMed ID: 6183456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The VAB-6 regimen in the treatment of metastatic seminoma.
    Vugrin D; Whitmore WF
    Cancer; 1984 Jun; 53(11):2422-4. PubMed ID: 6201259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumors.
    Vugrin D; Whitmore WF; Golbey RB
    Cancer; 1983 Mar; 51(6):1072-5. PubMed ID: 6185211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ cell tumors (II): VAB II in metastatic testicular cancer.
    Cheng E; Cvitkovic E; Wittes RE; Golbey RB
    Cancer; 1978 Nov; 42(5):2162-8. PubMed ID: 82473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VAB-3 combination chemotherapy of metastatic testicular cancer.
    Reynolds TF; Vugrin D; Cvitkovic E; Cheng E; Braun DW; O'Hehir MA; Dukeman ME; Whitmore WF; Golbey RB
    Cancer; 1981 Aug; 48(4):888-98. PubMed ID: 6168360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy with VAB-3 of stage II-B testicular cancer.
    Vugrin D; Whitmore W; Cvitkovic E; Grabstald H; Sogani P; Golbey RB
    Cancer; 1981 Jul; 48(2):233-7. PubMed ID: 6165458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of VAB-6 combination chemotherapy on malignant germ cell tumours in childhood.
    Hayashi Y; Ohi R; Konno T; Tsuchiya S; Muraosa Y; Yaoita S; Watanabe T
    Z Kinderchir; 1989 Aug; 44(4):208-12. PubMed ID: 2477963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VAB-4 combination chemotherapy in the treatment of metastatic testis tumors.
    Vugrin D; Cvitkovic E; Whitmore WF; Cheng E; Golbey RB
    Cancer; 1981 Mar; 47(5):833-9. PubMed ID: 6164466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [VAB-6 combination chemotherapy in patients with stage II, III testicular tumor].
    Hida S; Kawakita M; Takenawa J; Fukuzawa S; Okuno H; Yamauchi T; Oishi K; Nishio Y; Takeuchi H; Okada K
    Hinyokika Kiyo; 1986 Dec; 32(12):1849-58. PubMed ID: 2435134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
    Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
    J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infusion of high doses of platidiam in the treatment of patients with germ cell testicular tumors].
    Tiuliandin SA
    Vopr Onkol; 1990; 36(1):89-92. PubMed ID: 1689528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.
    Bosl GJ; Gluckman R; Geller NL; Golbey RB; Whitmore WF; Herr H; Sogani P; Morse M; Martini N; Bains M
    J Clin Oncol; 1986 Oct; 4(10):1493-9. PubMed ID: 2428948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients.
    Motzer RJ; Geller NL; Bosl GJ
    Cancer; 1990 Sep; 66(5):857-61. PubMed ID: 1696846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VAB-3 combination chemotherapy in primary mediastinal germ cell tumors.
    Vugrin D; Martini N; Whitmore WF; Golbey RB
    Cancer Treat Rep; 1982 Jun; 66(6):1405-7. PubMed ID: 6177411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
    Bosl GJ; Geller NL; Vogelzang NJ; Carey R; Auman J; Whitmore WF; Herr H; Morse M; Sogani P; Chan E
    J Clin Oncol; 1987 Mar; 5(3):436-40. PubMed ID: 2434627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of chemotherapy in patients with disseminated testicular tumors].
    Abdyldaev TA; Tiuliandin SA; Batov SV
    Vopr Onkol; 1990; 36(1):85-9. PubMed ID: 1689527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.